EV/EBITDA:
85.46+1.80(+2.15%)Summary
- As of today (July 16, 2025), TGTX EV/EBITDA is 85.46, with a rise of +1.80 (+2.15%) during the current trading session.
- Over the past year, TGTX EV/EBITDA has increased by +52.95 (+162.87%).
- TGTX EV/EBITDA is now -90.89% below its all-time high of 937.93.
Performance
TGTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TGTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.1% | +2.1% | +2.1% |
| 1 m1 month | +9.0% | +9.0% | +8.8% |
| 3 m3 months | +1.5% | +1.5% | +1.4% |
| 6 m6 months | -7.4% | +30.6% | +33.0% |
| ytdytd | -10.0% | +27.0% | +28.8% |
| 1 y1 year | +162.9% | +70.9% | +72.1% |
| 5 y5 years | +753.4% | +132.5% | +74.5% |
TGTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 85.82 | -0.4% | 77.00 | +11.0% |
| 3 m | 3-month | 100.66 | -15.1% | 73.33 | +16.5% |
| 6 m | 6-month | 107.38 | -20.4% | 65.23 | +31.0% |
| 1 y | 1-year | 937.93 | -90.9% | 25.37 | +236.8% |
| 3 y | 3-year | 937.93 | -90.9% | -74.07 | +215.4% |
| 5 y | 5-year | 937.93 | -90.9% | -74.07 | +215.4% |
| alltime | all time | 937.93 | -90.9% | -74.07 | +215.4% |
TGTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 85.46(-10.0%) |
| 2024 | 94.92(-4.7%) |
| 2023 | 99.60(-1338.8%) |
| 2022 | -8.04(+9.8%) |
| 2021 | -7.32(-70.6%) |
| 2020 | -24.94(+265.2%) |
| 2019 | -6.83(+290.3%) |
| 2018 | -1.75(-62.2%) |
| Date | Value |
|---|---|
| 2017 | -4.63(+52.8%) |
| 2016 | -3.03(-67.6%) |
| 2015 | -9.34(-20.7%) |
| 2014 | -11.78(+144.9%) |
| 2013 | -4.81(+48.9%) |
| 2012 | -3.23(>+9900.0%) |
| 2011 | -0.01(-99.8%) |
| 2010 | -5.30 |
FAQ
- What is TG Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for TG Therapeutics, Inc.?
- What is TGTX EV/EBITDA year-to-date change?
- What is TG Therapeutics, Inc. EV/EBITDA year-on-year change?
What is TG Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TGTX is 85.46
What is the all time high EV/EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high EV/EBITDA is 937.93
What is TGTX EV/EBITDA year-to-date change?
TG Therapeutics, Inc. EV/EBITDA has changed by -9.46 (-9.97%) since the beginning of the year
What is TG Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TGTX EV/EBITDA has changed by +52.95 (+162.87%)